Li Kang Biomedical Co Ltd (6242) — Strategic Asset Allocation Index
Li Kang Biomedical Co Ltd (6242) has a Strategic Asset Allocation Index of 46.9% as of June 2023. Strategic assets (PP&E of NT$272.48 Million plus long-term investments of NT$-) total NT$272.48 Million, measured against net assets of NT$580.65 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 6242 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Li Kang Biomedical Co Ltd Strategic Asset Allocation Index (2002–2022)
This chart shows how Li Kang Biomedical Co Ltd's Strategic Asset Allocation Index has evolved across 21 annual periods from 2002 to 2022. As of June 2023, the index stands at 46.9%, representing strategic assets of NT$272.48 Million against net assets of NT$580.65 Million TWD. For live market cap and overall valuation, see how much is Li Kang Biomedical Co Ltd worth.
Annual Strategic Asset Allocation Index for Li Kang Biomedical Co Ltd (2002–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Li Kang Biomedical Co Ltd from 2002 to 2022, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Li Kang Biomedical Co Ltd net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 48.5% | NT$276.68 Million | NT$276.68 Million | NT$- | NT$570.14 Million | ▼ -25.1 pp |
| 2021 | 73.7% | NT$362.40 Million | NT$362.40 Million | NT$- | NT$492.00 Million | ▲ +0.7 pp |
| 2020 | 72.9% | NT$370.66 Million | NT$370.66 Million | NT$- | NT$508.30 Million | ▼ -6.5 pp |
| 2019 | 79.5% | NT$384.13 Million | NT$384.13 Million | NT$- | NT$483.44 Million | ▼ -6.5 pp |
| 2018 | 86.0% | NT$401.43 Million | NT$401.43 Million | NT$- | NT$466.92 Million | ▲ +9.2 pp |
| 2017 | 76.8% | NT$342.14 Million | NT$342.14 Million | NT$- | NT$445.68 Million | ▼ -28.2 pp |
| 2016 | 105.0% | NT$357.85 Million | NT$357.85 Million | NT$- | NT$340.80 Million | ▼ -28.2 pp |
| 2015 | 133.2% | NT$373.24 Million | NT$373.24 Million | NT$- | NT$280.29 Million | ▲ +127.3 pp |
| 2014 | 5.9% | NT$13.36 Million | NT$13.36 Million | NT$- | NT$227.44 Million | ▼ -14.5 pp |
| 2013 | 20.4% | NT$4.95 Million | NT$4.95 Million | NT$- | NT$24.29 Million | ▲ +12.7 pp |
| 2012 | 7.7% | NT$6.52 Million | NT$6.52 Million | NT$- | NT$85.12 Million | ▲ +2.2 pp |
| 2011 | 5.4% | NT$6.72 Million | NT$6.72 Million | NT$- | NT$123.43 Million | ▲ +1.1 pp |
| 2010 | 4.3% | NT$4.51 Million | NT$4.51 Million | NT$- | NT$104.31 Million | ▼ -33.4 pp |
| 2009 | 37.8% | NT$48.51 Million | NT$48.51 Million | NT$- | NT$128.49 Million | ▲ +1.0 pp |
| 2008 | 36.7% | NT$70.24 Million | NT$70.24 Million | NT$- | NT$191.32 Million | ▲ +17.7 pp |
| 2007 | 19.0% | NT$78.22 Million | NT$78.22 Million | NT$- | NT$411.54 Million | ▼ -85.1 pp |
| 2006 | 104.1% | NT$224.78 Million | NT$224.78 Million | NT$- | NT$215.94 Million | ▼ -18.0 pp |
| 2005 | 122.1% | NT$272.73 Million | NT$272.73 Million | NT$- | NT$223.45 Million | ▲ +32.9 pp |
| 2004 | 89.2% | NT$288.44 Million | NT$288.44 Million | NT$- | NT$323.44 Million | ▼ -0.9 pp |
| 2003 | 90.1% | NT$304.55 Million | NT$304.55 Million | NT$- | NT$338.06 Million | ▼ -5.0 pp |
| 2002 | 95.1% | NT$330.53 Million | NT$330.53 Million | NT$- | NT$347.64 Million | — |